A novel telomere-associated genes signature for the prediction of prognosis and treatment responsiveness of hepatocellular carcinoma

Table 3 Five methodologies were employed to evaluate the causal association between ASF1A and the susceptibility to HCC

Exposure	Method	N snp	OR	95% CI	P
ASF1A	MR Egger	5	1.748	0.25–12.20	0.61
	Weighted median	5	2.716	0.77–9.63	0.12
	Inverse variance weighted	5	3.325	1.20–9.22	0.02
	Simple mode	5	2.702	0.54–13.57	0.29
	Weighted mode	5	2.499	0.56–11.22	0.30

ISSN: 1480-9222